Coherus BioSciences logo
Coherus BioSciences CHRS
$ 1.47 -0.68%

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Coherus BioSciences Financial Ratios 2011-2024 | CHRS

Annual Financial Ratios Coherus BioSciences

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.9 -1.8 -3.2 10.2 14.3 -4.1 -2.4 -9.2 -2.2 -2.1 - - -

P/S

0.8 2.5 2.9 2.8 3.6 - 374.8 6.2 16.4 5.9 - - -

EPS

-2.5 -3.8 -3.8 1.9 1.3 -3.2 -4.5 -3.0 -6.0 -10.6 -16.1 -15.8 -

EV (Enterprise Value)

929 M 1.08 B 1.1 B 1.36 B 1.41 B 916 M 588 M 1.21 B 553 M 154 M 50.3 M 2.79 M -

EBITDA per Share

-2.12 -3.26 -3.45 2.23 1.59 -3.09 -4.3 -2.69 -5.85 -7.82 - - -

EV/EBITDA

-4.1 7.7 11.6 -4.4 -2.4 -10.2 -1.5 -0.5 0.7 - -

PEG

0.01 0.02 0.05 -0.38 0.1 -0.14 0.05 -0.19 -0.05 0.01 - - -

P/B

-1.1 -3.8 9.5 4.8 12.2 -22.0 19.1 60.5 -71.0 2.8 - - -

P/CF

-1.2 -2.2 -24.9 8.7 83.1 -5.3 -2.8 -4.5 -4.3 -6.9 - - -

ROE %

122.99 212.31 -293.78 47.07 85.38 542.46 -779.99 -657.94 3222.11 -130.52 55.25 - -

ROA %

-37.78 -60.68 -42.26 15.71 21.97 -210.46 -146.47 -71.34 -105.12 -46.54 -113.04 - -

ROCE %

105.05 186.93 -270.00 55.63 36.66 -308.76 -172.96 -94.94 -205.96 -47.76 772.98 - -

Current Ratio

0.8 0.8 1.2 1.5 3.0 2.5 5.1 2.9 1.9 3.5 0.9 - -

DSO

262.8 201.5 156.5 114.7 145.6 - - 3.6 19.0 49.7 36.9 - -

DIO

116.4 199.0 259.5 261.8 209.6 - - - - - - - -

DPO

53.7 72.1 99.4 199.5 555.4 - - - - - - - -

Operating Cycle

379.2 400.5 416.0 376.5 355.2 - - - - - - - -

Cash Conversion Cycle

325.6 328.4 316.6 177.0 -200.2 - - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Coherus BioSciences

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.09 -0.11 0.91 - -0.41 -0.49 -0.96 - -1.11 -0.65 -1.24 - -0.49 -0.4 -2.37 - 0.39 0.83 0.5 0.56 0.67 0.34 -0.29 -0.92 -0.87 -0.68 -0.74 -0.84 -1.09 -1.08 -1.54 -1.71 1.93 -1.72 -1.67 -1.35 -1.86 -1.56 -1.22 -1.47 -1.79 -5.96 -6.03 -3.68 -6.23 -2.8 -3.14 - - - - - - - -

EBITDA per Share

-0.05 -0.17 -0.37 - -0.32 -0.39 -0.84 - -1.02 -0.56 -1.04 - -0.4 -0.31 -2.29 - 0.48 0.93 0.59 - 0.75 0.41 -0.23 - -0.83 -0.69 -0.68 - -1.03 -1.09 -1.47 - 1.96 -1.52 -1.63 - -1.84 -1.55 -1.09 - -1.35 -3.85 -2.82 - -1.38 - - - - - - - - - -

ROE %

-68.44 -50.99 -41.82 92.74 181.95 241.48 438.57 -453.99 -483.46 -602.13 -842.89 -184.07 -174.13 -134.72 -94.57 43.61 80.89 115.66 117.05 85.38 210.30 -308.90 -400.37 2087.81 1764.92 2054.05 1949.24 -754.91 -964.07 -369.79 -536.77 -620.34 593.58 1333.91 2622.25 3596.91 2709.23 1548.20 563.36 -130.44 -71.79 -37.89 -0.53 37.15 22.12 - - - - - - - - - -

ROA %

2.64 -2.02 -9.24 -34.74 -50.47 -59.40 -66.47 -48.11 -53.31 -26.58 -30.62 -34.18 -30.86 -22.35 -11.29 14.56 24.15 32.34 31.09 21.97 -50.56 -121.18 -170.82 -210.46 -177.70 -154.86 -145.01 -146.47 -158.83 -75.52 -80.69 -71.34 -53.47 -134.09 -122.58 -105.12 -96.01 -66.63 -52.27 -46.54 -61.73 -102.78 -89.45 -76.01 -45.26 - - - - - - - - - -

ROCE %

107.56 124.26 119.64 78.20 161.02 219.89 394.62 -366.83 -391.91 -499.80 -709.77 -171.63 -159.63 -122.56 -83.84 49.79 99.06 136.33 139.22 59.63 -400.05 -908.99 -1006.22 1812.16 1634.25 1916.03 1809.15 -583.43 -171.20 418.92 291.26 -206.90 940.46 1675.61 2930.08 2688.26 2678.64 1521.66 545.96 -57.07 -50.08 -33.48 -6.63 6.99 6.99 - - - - - - - - - -

Current Ratio

0.8 0.9 0.9 0.8 0.8 0.7 0.7 0.8 0.8 - 1.0 1.2 1.2 1.3 1.2 1.5 1.5 1.5 1.5 1.4 1.4 1.4 1.4 0.7 0.7 0.7 0.7 1.2 1.2 1.2 1.2 1.1 1.1 1.1 1.1 1.0 1.0 1.0 1.0 1.6 1.6 1.6 1.6 0.5 0.5 - - - - - - - - - -

DSO

221.0 300.0 303.4 - 218.9 188.6 297.4 - 91.6 88.8 182.2 - 153.8 146.9 163.4 - 126.2 105.6 117.4 104.6 116.0 155.3 174.6 - - - - - - 0.8 534.2 201.0 1.0 12.1 12.6 14.0 19.9 20.7 31.2 34.0 13.7 44.4 34.2 10.3 - - - - - - - - - - -

DIO

241.5 199.7 164.3 - 182.4 208.2 238.5 - 35.9 149.5 363.2 - 165.6 249.4 582.2 - 448.5 398.1 359.7 - - 1489.0 235.1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

217.1 185.1 97.0 - 92.6 96.4 94.0 - 12.8 85.3 181.4 - 129.2 82.1 186.4 - 154.1 136.8 274.1 - - 3945.3 846.5 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

462.5 499.6 467.8 - 401.4 396.9 535.9 - 127.5 238.2 545.4 - 319.5 396.4 745.6 - 574.7 503.7 477.1 104.6 116.0 1644.3 409.8 - - - - - - 0.8 534.2 201.0 1.0 12.1 12.6 14.0 19.9 20.7 31.2 34.0 13.7 44.4 34.2 10.3 - - - - - - - - - - -

Cash Conversion Cycle

245.4 314.5 370.8 - 308.8 300.4 441.9 - 114.6 152.9 364.0 - 190.2 314.2 559.3 - 420.6 366.9 203.0 104.6 116.0 -2301.0 -436.7 - - - - - - 0.8 534.2 201.0 1.0 12.1 12.6 14.0 19.9 20.7 31.2 34.0 13.7 44.4 34.2 10.3 - - - - - - - - - - -

All numbers in USD currency